The stock has declined recently. The Company is engaged in developing products for companion animals, such as canine, feline, and equine by focusing on needs of clinical veterinarians. Its lead drug product candidate is ZM-007, an oral suspension formulation of metronidazole for the treatment of acute diarrhea in small dog breeds and puppies. Zomedica Corp., formerly Zomedica Pharmaceuticals Corp., is a development stage veterinary diagnostic and pharmaceutical company. Recurring Once. Zomedica finds itself well above its 200-day moving average but also well below its 50-day moving average, which paints a picture of the stock’s recent volatility. Show recent events. ANN ARBOR, Mich., Feb. 26, 2021 (GLOBE NEWSWIRE) — Zomedica Corp. (NYSE American:ZOM) (“Zomedica” or the “Company”), a veterinary health company creating point-of-care diagnostics products for dogs and cats, today reported consolidated financial results for the year ended December 31, 2020. With that report coming out after-hours, it appears that the movement for ZOM stock today is connected to that release. Launch Team" for Upcoming TRUFORMA™ Commercialization ... or statements that certain events … Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 8.9%. ANN ARBOR, Mich., Dec. 07, 2020 (GLOBE NEWSWIRE) -- Zomedica Corp. (NYSE American: ZOM) (“Zomedica” or the “Company”), a veterinary health company creating point-of-care diagnostics products for dogs and cats, today announced that, with the hiring of Debra Rock to lead the Company’s Marketing Department, its internal commercial leadership team is complete. Zomedica (ZOM) expects to begin commercial sales of TRUFORMA on March 30, 2021. Upcoming Events for ZOM. ANN ARBOR, Mich., March 16, 2021 (GLOBE NEWSWIRE) -- Zomedica Corp. (NYSE American: ZOM) (“Zomedica” or the “Company”), a veterinary health company creating point-of-care diagnostics products for dogs and cats, yesterday recorded the first veterinarian sale of TRUFORMA ® and officially entered commercialization. Zomedica's TRUFORMA platform could disrupt the $2.8 billion vet diagnostics market and propel ZOM stock above $3. Show recent events. ... Upcoming Events. The Company is engaged in developing products for companion animals, such as canine, feline, and equine by focusing on needs of clinical veterinarians. Joining Zomedica as … Progress Continuing Toward Commercialization of TRUFORMA™ANN ARBOR, Mich., Dec. 15, 2020 (GLOBE NEWSWIRE) -- Zomedica Corp. (NYSE American: ZOM) (“Zomedica” or the “Company”), a veterinary health company creating point-of-care diagnostics products for dogs and cats, today announced that while a majority of shareholders voted at its Special Virtual-Only Meeting of … ... Upcoming Events for ZOM. Amounts, unless specified otherwise, are expressed in U.S. dollars and presented … Shares have rallied from 6 cents in November to highs of $2.91 this year. Upcoming event on ZOMEDICA CORP. 05/18/21: Company calendar. The 2021 estimates are for Zomedica Corp. earnings to increase by 75.1%, but the outlook for the next 5 … Click here now. --Zomedica Corp., a veterinary health company creating point-of-care diagnostics products for dogs and cats, today announced that, with the hiring of … Against this backdrop, we think shares of veterinary diagnostic company Zomedica Corp. (ZOM) are well-positioned to gain ahead of the company’s forthcoming launch of its flagship Truforma point-of-care diagnostic platform in March. Amounts, unless specified otherwise, are expressed in U.S. dollars and presented … Zomedica shares have suffered since sale of its first Truforma product. Accordingly, I’d advise investors to be cautious on headline-trading equities such as ZOM stock right now. Follow Zomedica Pharma's earnings. ANN ARBOR, Mich., Feb. 26, 2021 (GLOBE NEWSWIRE) -- Zomedica Corp. (NYSE American:ZOM) (“Zomedica” or the “Company”), a veterinary health company creating point-of … The most tangible events were twofold. Zomedica isn’t the only game in town, and this is a competitive space. Get the hottest stocks to trade every day before the market opens 100% free. To start off with Zomedica, reported losses per share of 5 cents for the year. About Zomedica (ZOM) Based in Ann Arbor, Michigan, Zomedica (ZOM) is a veterinary health company creating products for dogs and cats by focusing on the unmet needs of clinical veterinarians. There are no upcoming events for ZOM. About Zomedica Based in Ann Arbor, Michigan, Zomedica (NYSE American: ZOM) is a veterinary health company creating products for dogs and … We note from Zomedica Corp.’s average daily trading volume that its 10-day average is 45.2 Million shares, with the 3-month average coming to 161.23 Million. Friday 26th February, 2021 Q4 2020 Zomedica Corp Earnings Release Thursday 12th November, 2020 ... Zomedica is scheduled to issue upcoming financial results on the following dates: Interim results are scheduled for: 2021-12-31. In the a press release, Zomedica’s CEO, Robert Cohin, issued a letter to shareholders surrounding several key events taking place ahead of the launch of the TRUFORMA diagnostics platform. So, the question is, can it regain its rally based on the sale of its Truforma diagnostic product … ZOM shares recovered on Friday, closing up 2%. ... Fast forward a year, and Zomedica had sold more than 320 million new shares of ZOM stock to the public. Zomedica Corp., formerly Zomedica Pharmaceuticals Corp., is a development stage veterinary diagnostic and pharmaceutical company. More From InvestorPlace Why … Zomedica Corp. (ZOM) estimates and forecasts. Zomedica Corp.(NYSE:ZOM): Pet care stocks have been on a solid run of late as homebound lifestyles have caused more Americans to adopt pets. About Zomedica Based in Ann Arbor, Michigan, Zomedica (NYSE American: ZOM) is a veterinary health company creating products for dogs and … 03/31/21: WUXI APPTEC CO., LTD.: FY 2020 Earnings Release: 04/23/21: SHANGHAI RAAS BLOOD PRODUCTS CO., LTD.: FY 2020 Earnings Release: 04/23/21: HUALAN BIOLOGICAL ENGINEERING INC.: Q1 2021 Earnings Release (Projected) Zomedica Corp., formerly Zomedica Pharmaceuticals Corp., is a development stage veterinary diagnostic and pharmaceutical company. Upcoming events on ZOMEDICA CORP. 03/03/21 : FY 2020 Earnings Release (Projected) 05/18/21 : Q1 2021 Earnings Release (Projected) 08/12/21 : Interim 2021 Earnings Release (Projected) 11/16/21 : Q3 2021 Earnings Release (Projected) Past events on ZOMEDICA CORP. 12/15/20 : Extraordinary Shareholders Meeting: I think it unlikely that this valuation will hold up over the long-term, but I’ve been wrong once or twice. Upcoming sector events. Zomedica Corp.(NYSE:ZOM): Zomedica (ZOM), which develops diagnostic and pharmaceutical products for companion animals, saw little share price fluctuation over the past few years until the penny stock soared after being promoted on Netflix earlier this year. ANN ARBOR, Mich., Feb. 26, 2021 (GLOBE NEWSWIRE) -- Zomedica Corp. (NYSE American:ZOM) (“Zomedica” or the “Company”), a veterinary health company creating point-of-care diagnostics products for dogs and cats, today reported consolidated financial results for the year ended December 31, 2020. Frequency. About Zomedica Based in Ann Arbor, Michigan, Zomedica (NYSE American: ZOM) is a veterinary health company creating products for dogs and … The Company is engaged in developing products for companion animals, such as canine, feline, and equine by focusing on needs of clinical veterinarians. Zomedica Corp., a development stage veterinary diagnostic and pharmaceutical company, engages in the discovery, development, and commercialization of pharmaceuticals for the companion pet. The stock is still up significantly in 2021 as retail investors back it … #4: Zomedica Corp. Zomedica is a long-standing name on our lists of penny stocks to watch. For all future releases Just for the upcoming release Send me a reminder 1 trading day before Zomedica closed a $30 million public offering on July 7, following a $20 million public offering in May.